AbbVie stockABBV
AbbVie trades at $288.24, 4.8% below its 52-week high (Nov 5, 2026). The price is above its 50- and 200-day averages, i.e. in an uptrend. +28.2% year to date, +35.2% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Feb 3, 2027.
Ratings, candles, signals and the screener for ABBV — after you log in
Open the terminalFrequently asked questions about AbbVie
What is the AbbVie stock price?
At the close on Nov 5, 2026: $288.24 (−2.24% on the day). 52-week high: $302.93 on Nov 5, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does AbbVie report earnings?
The next quarterly report is on Feb 3, 2027. Last quarter, earnings per share changed +105% year over year, revenue +10%.
Does AbbVie pay dividends?
Yes, the dividend yield is about 2.47% a year.
Where does AbbVie trade and how to buy it?
Ticker ABBV, exchange NYSE. You can buy it through a broker with access to US exchanges.
Should I buy AbbVie now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for ABBV are in the terminal after you log in.